Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.255 USD | +2.03% | -3.12% | +5.98% |
13/05 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
09/05 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.98% | 91.92M | |
+4.42% | 111B | |
+10.95% | 105B | |
-12.01% | 22.34B | |
-3.81% | 21.93B | |
-5.94% | 18.59B | |
-36.52% | 18.12B | |
-10.04% | 16.96B | |
+3.07% | 13.7B | |
+37.10% | 12.45B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Wedbush Adjusts Clearside Biomedical Price Target to $4 From $6, Maintains Outperform Rating